ADPT Insider Trading Activity and SEC Form 4 Filings
ADPT insider trading summary
Over the past 12 months, insiders at Adaptive Biotechnologies Corp (ADPT) reported 162 sales worth $120.4M by 11 insiders and no open-market purchases on SEC Form 4. Net insider selling was $120.4M.
Latest ADPT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Julie Rubinstein | President and COO | Sell | $309K (11,881 @ $25.98) |
| Nov 2, 2026 | Julie Rubinstein | President and COO | Sell | $68K (2,585 @ $26.34) |
| Nov 2, 2026 | Julie Rubinstein | President and COO | Sell | $235K (9,296 @ $25.23) |
| Oct 30, 2026 | Julie Rubinstein | President and COO | Sell | $252K (9,486 @ $26.55) |
| Oct 30, 2026 | Julie Rubinstein | President and COO | Sell | $66K (2,395 @ $27.45) |
| Oct 29, 2026 | Julie Rubinstein | President and COO | Sell | $336K (11,881 @ $28.27) |
| Oct 28, 2026 | Julie Rubinstein | President and COO | Sell | $6K (200 @ $28.90) |
| Oct 28, 2026 | Julie Rubinstein | President and COO | Sell | $332K (11,681 @ $28.44) |
| Oct 27, 2026 | Julie Rubinstein | President and COO | Sell | $80K (3,000 @ $26.58) |
| Oct 27, 2026 | Julie Rubinstein | President and COO | Sell | $244K (8,881 @ $27.53) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.